Effect of Diacerein on Metabolic Control and Inflammatory Markers in Patients with Type 2 Diabetes Using Antidiabetic Agents: A Randomized Controlled Trial

INTRODUCTION: Studies have shown that T2DM is an inflammatory disease. Thus, the present study was aimed at evaluating whether diacerein could improve the metabolic and inflammatory profile among patients with T2DM under long-term treatment with glucose-lowering agents. METHODS: This is a double-bli...

Descripción completa

Detalles Bibliográficos
Autores principales: Tres, Glaucia S., Fuchs, Sandra C., Piovesan, Fabiana, Koehler-Santos, Patricia, Pereira, Fernanda dos S., Camey, Suzi, Lisboa, Hugo K., Moreira, Leila B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902058/
https://www.ncbi.nlm.nih.gov/pubmed/29805981
http://dx.doi.org/10.1155/2018/4246521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902058/
https://www.ncbi.nlm.nih.gov/pubmed/29805981
http://dx.doi.org/10.1155/2018/4246521

Ejemplares similares